Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NHKC-1 24-hour ambulatory blood pressure monitoring in hypertension
CTR20230972Phase 3Completed
- Sponsor
- Sunshine Novo
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan + levamlodipine in essential hypertension, hypertension (HTN), sponsored by Sunshine Novo. Started Apr 2023; status: completed.
02
Drugs
valsartan + levamlodipine
03
Conditions
essential hypertensionhypertension (HTN)
Beyond the preview
Go deeper on CTR20230972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230972.